Avestar Capital’s InspireMD NSPR Stock Holding History

Avestar Capital’s Portfolio NSPR Stock Details NSPR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$10.5K	Hold	15,000	–	–	﹤0.01%	544
2026 Q1	$24.4K	Hold	15,000	–	–	﹤0.01%	508
2025 Q4	$26.7K	Hold	15,000	–	–	﹤0.01%	481
2025 Q3	$36.1K	Hold	15,000	–	–	﹤0.01%	476
2025 Q2	$34K	Hold	15,000	–	–	﹤0.01%	489
2025 Q1	$40.4K	Hold	15,000	–	–	﹤0.01%	480
2024 Q4	$39.5K	Hold	15,000	–	–	﹤0.01%	516
2024 Q3	$40.2K	Sell	15,000 -5,000	-25%	-$13.6K	﹤0.01%	467
2024 Q2	$49.9K	Hold	20,000	–	–	0.01%	449
2024 Q1	$47.4K	Hold	20,000	–	–	0.01%	456
2023 Q4	$56.2K	Hold	20,000	–	–	0.01%	382
2023 Q3	$65.4K	Buy	+20,000	New	+$63.9K	0.01%	357
2022 Q4	–	Sell	-10,000	Closed	-$15K	–	335
2022 Q3	$15K	Hold	10,000	–	–	﹤0.01%	278
2022 Q2	$20K	Hold	10,000	–	–	﹤0.01%	288
2022 Q1	$32K	Hold	10,000	–	–	0.01%	391
2021 Q4	$30K	Buy	+10,000	New	+$37.5K	﹤0.01%	422

Other funds holding NSPR

Rosalind Advisors Toronto, Ontario, Canada $269M AUM 103.38% 1-Year Est. Return

Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return

NCM

Nantahala Capital Management New Canaan, Connecticut $3.01B AUM 119.46% 1-Year Est. Return

OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return

PHP

Parkman Healthcare Partners Stamford, Connecticut $977M AUM 110.37% 1-Year Est. Return

Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return

SCM

Soleus Capital Management Greenwich, Connecticut $2.9B AUM 169.69% 1-Year Est. Return

PVI

Pura Vida Investments New York $37M AUM 63.54% 1-Year Est. Return

ISL

Ingalls & Snyder LLC New York $3.66B AUM 57.76% 1-Year Est. Return

Affiance Financial St. Louis Park, Minnesota $695M AUM 17.33% 1-Year Est. Return

Avestar Capital's NSPR Position: Q2 2026 in Review

Avestar Capital held its InspireMD (NSPR) position steady in Q2 2026 at 15,000 shares worth $10.5K. The position accounts for ﹤0.01% of the portfolio, ranked #544.

Avestar Capital first reported a position in NSPR in Q4 2021 and has held it in 16 quarters since. The position peaked at $65.4K in Q3 2023. 37 funds tracked by Wall St. Rank hold NSPR as of Q2 2026.

Avestar Capital held 15,000 shares of InspireMD worth $10.5K as of Q2 2026.
Avestar Capital left its InspireMD share count unchanged in Q2 2026.
InspireMD made up ﹤0.01% of Avestar Capital's portfolio in Q2 2026, its #544 holding.
Avestar Capital first reported a position in InspireMD in Q4 2021 and has held it in 16 quarters since.
Avestar Capital's InspireMD position peaked at $65.4K in Q3 2023.
37 funds tracked by Wall St. Rank held InspireMD as of Q2 2026.

Based on Avestar Capital's 13F filing for Q2 2026, filed 29 Jul 2026.